Cytomx Therapeutics Inc Stock
Cytomx Therapeutics Inc Stock
A loss of -1.270% shows a downward development for Cytomx Therapeutics Inc.
The community is currently still undecided about Cytomx Therapeutics Inc with 1 Buy predictions and 1 Sell predictions.
With a target price of 50 € there is potential for a 3123.73% increase which would mean more than doubling the current price of 1.55 € for Cytomx Therapeutics Inc.
Our community identified positive and negative aspects for Cytomx Therapeutics Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cytomx Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Cytomx Therapeutics Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cytomx Therapeutics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cytomx Therapeutics Inc | -1.270% | -2.905% | -62.290% | -2.543% | 12.536% | -71.488% | - |
Evolus Inc | 2.610% | 2.609% | 0.000% | 44.785% | 30.387% | 26.203% | - |
Ardelyx Inc. | 3.070% | 1.608% | 0.032% | 93.211% | 9.308% | 11.823% | - |
Salarius Pharmaceuticals Inc. | - | -3.015% | -16.087% | -67.833% | -30.450% | -98.515% | -99.994% |